Skip to main content
Premium Trial:

Request an Annual Quote

BU Researchers Under Fire for Misconduct

The Office of Research Integrity has found that Boston University cancer researcher Shen Wang made up experiments that he reported in two NCI- and NIH-funded studies, and engaged in "research misconduct," reports Retraction Watch's Ivan Oransky. The two papers, published in Molecular Endocrinology and Oncogene in 2009, have been retracted and Wang has accepted ORI's findings of misconduct, though he hasn't admitted or denied that he did indeed falsify data, Oransky says. He also agreed to exclude himself from any "contracting or subcontracting with any agency of the United States Government and from eligibility or involvement in nonprocurement programs of the United States Government," and from serving on any advisory capacity to the US Public Health Service, the ORI notice states. In a statement provided to Oransky by Boston University, the school says Wang no longer works there, but didn't say on what terms he left.

The Boston Globe's Carolyn Johnson reports that the ORI decision resulted from an internal review process initiated by Boston University, and that Wang was found to have fabricated experiments used in six out of seven figures published in one paper, and six out of eight figures published in the other. Both papers explored the role of the HIC1 tumor suppressor gene. "According to Google Scholar, the Oncogene paper had been cited 13 times in journal articles by other scientists, and the Molecular Endocrinology paper had been cited twice, small numbers that suggest the work had not been very influential," Johnson says. "The fabricated figures in both cases include multiple charts that were used to show the outcomes of experiments that used tools to measure gene activity or the interactions between proteins and DNA."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.